BioSpace News Archive

Biotech Beach

Pipeline Therapeutics Announces Participation in Upcoming Investor Conferences in November 2022

Pipeline Therapeutics announced that management will present at the following investor conferences during November 2022.

November 1, 2022
·
1 min read
Business

Mirum Pharmaceuticals to Announce Third Quarter 2022 Financial Results and Host Conference Call on November 9, 2022

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) today announced that it will report third quarter financial results on Wednesday, November 9, 2022.

November 1, 2022
·
2 min read
Business

Michael Aldridge, Seasoned Biotech Executive, Appointed CEO of Focal Medical

Focal Medical, Inc., a privately held, biopharmaceutical company developing novel therapeutic products based on its innovative local drug delivery technology platform, announced the appointment of Michael Aldridge as the Company’s new Chief Executive Officer.

November 1, 2022
·
5 min read
Business

Shattuck Labs to Report Third Quarter 2022 Financial Results on November 8, 2022

Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK) today announced it will report third quarter 2022 financial results and provide a general business overview on Tuesday, November 8, 2022.

November 1, 2022
·
2 min read
Drug Development

Eloxx Pharmaceuticals Announces Opening of Clinical Trial Sites for Phase 2 Study of ELX-02 for the Treatment of Alport SyndromeTrial sites now open in Australia and the United Kingdom

Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX), a leader in ribosomal RNA-targeted genetic therapies for rare diseases, today announced the opening of clinical trial sites for its Phase 2 study of ELX-02 for the treatment of Alport syndrome in patients with nonsense mutations.

November 1, 2022
·
5 min read
Business

Viemed Healthcare Announces Third Quarter 2022 Financial Results

Viemed Healthcare, Inc. announced that it has reported its financial results for the three and nine months ended September 30, 2022.

November 1, 2022
·
16 min read
Business

Novavax Appoints Rick Rodgers to Board of Directors

Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, announced the appointment of Richard Rodgers, MBA to its board as an independent director.

November 1, 2022
·
5 min read
Business

Movano Inc. to Report Third Quarter 2022 Financial Results on Monday, November 14, 2022

Movano Inc. (NASDAQ:MOVE) dba Movano Health, a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices, today announced that it will report third quarter 2022 financial and operating results on Monday, November 14, 2022.

November 1, 2022
·
2 min read
Business

Quanterix’ Third Quarter 2022 Earnings Conference Call

Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced it will host a conference call on Tuesday, November 8, 2022, to discuss its third quarter 2022 financial results.

November 1, 2022
·
2 min read
Genetown

ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - November 01, 2022

ImmunoGen, Inc. announced that on October 31, 2022, the compensation committee of the Company’s Board of Directors approved grants of non-qualified stock option awards to purchase an aggregate of 687,700 shares of its common stock to seventeen new employees under the ImmunoGen, Inc.

November 1, 2022
·
2 min read